effects [qlco]
Phytoestrogens [horm, phsu, strd]
Bone [bpoc]
turnover [qnco]
postmenopausal [tmco]
Women [popg]
History [ocdi]
Breast Cancer [neop]
Phyto-Estrogen [horm, phsu, strd]
Intake [ftcn]
Asian [popg]
Women [popg]
Thought [menp]
Low Risk [fndg]
Bone [bpoc]
Fracture [inpo]
randomized controlled trial [inpr, resa]
placebo [topp]
Study [mnob]
effects [qlco]
isoflavonoids [orch, vita]
Urinary output [clna]
Terminal [tmco]
Cross Linked [npop]
Type 1 Collagen [aapp, bacs]
pyridinoline [aapp, bacs]
deoxypyridinoline [aapp, bacs]
bone markers [medd]
Resorption [orgf]
Bone Specific Alkaline Phosphatase [lbpr]
Terminal [tmco]
C-Terminal [amas]
Procollagen Type I [aapp, bacs]
bone markers [medd]
formation [biof]
Five [qnco]
postmenopausal [tmco]
Women [popg]
History [ocdi]
Breast Cancer [neop]
Phytoestrogens [horm, phsu, strd]
mg% [qnco]
isoflavonoids [orch, vita]
placebo [topp]
Tablets [bodm]
Daily [tmco]
3 Months [tmco]
Treatment Regimen [topp]
Then [tmco]
cross over [genf]
Washout Period [tmco]
Marker [clna]
Measured [qlco]
Last [qlco]
treatment [ftcn]
Bone Resorption [ortf]
Reduced [qlco]
Phyto-Estrogen [horm, phsu, strd]
reflected [menp]
Falls [fndg]
Urinary output [clna]
pyridinoline [aapp, bacs]
P NOS [aapp, imft]
deoxypyridinoline [aapp, bacs]
P NOS [aapp, imft]
Compared [acty]
placebo [topp]
Group [idcn]
Fall [fndg]
deoxypyridinoline [aapp, bacs]
P NOS [aapp, imft]
0.022" [qnco]
Falls [fndg]
pyridinoline [aapp, bacs]
P NOS [aapp, imft]
Terminal [tmco]
Cross Linked [npop]
Type 1 Collagen [aapp, bacs]
P NOS [aapp, imft]
trend [tmco]
bone markers [medd]
formation [biof]
Affected [ftcn]
Regimen [topp]
Induced [ftcn]
Inhibition [menp]
Bone Resorption [ortf]
Contribute [acty]
Low Risk [fndg]
Osteoporosis [dsyn]
Asian [popg]
Women [popg]
